National Healthcare Properties (NASDAQ:NHP) Stock Picked Up by Analysts at Huntington

Huntington began coverage on shares of National Healthcare Properties (NASDAQ:NHP) in a note issued to investors on Wednesday, Zacks reports. The firm set a “strong-buy” rating on the stock.

NHP has been the subject of several other reports. Citigroup restated an “outperform” rating on shares of National Healthcare Properties in a report on Monday, August 10th. Raymond James Financial assumed coverage on shares of National Healthcare Properties in a report on Tuesday, October 13th. They set an “outperform” rating and a $20.00 target price on the stock. Royal Bank Of Canada raised their target price on shares of National Healthcare Properties from $15.00 to $17.00 and gave the company a “sector perform” rating in a research report on Monday, August 17th. Wells Fargo & Company reduced their price target on shares of National Healthcare Properties from $19.00 to $18.00 and set an “overweight” rating for the company in a report on Monday, October 19th. Finally, Citizens Jmp upped their price target on shares of National Healthcare Properties from $18.00 to $21.00 and gave the stock a “market outperform” rating in a research report on Monday, August 10th. One analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, five have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, National Healthcare Properties presently has an average rating of “Moderate Buy” and an average price target of $18.30.

National Healthcare Properties Stock Down 3.7%

Shares of NASDAQ NHP opened at $15.21 on Wednesday. The company has a current ratio of 0.79, a quick ratio of 0.79 and a debt-to-equity ratio of 0.45. The firm’s fifty day moving average price is $15.71. The company has a market cap of $1.11 billion and a price-to-earnings ratio of -117.00. National Healthcare Properties has a twelve month low of $11.25 and a twelve month high of $17.46.

National Healthcare Properties (NASDAQ:NHP) last issued its earnings results on Wednesday, November 4th. The company reported $0.24 earnings per share for the quarter, topping the consensus estimate of $0.18 by $0.06. National Healthcare Properties had a negative return on equity of 1.62% and a negative net margin of 3.35%. The business had revenue of $103.06 million during the quarter. On average, research analysts expect that National Healthcare Properties will post 0.75 earnings per share for the current year.

Hedge Funds Weigh In On National Healthcare Properties

Several institutional investors and hedge funds have recently added to or reduced their stakes in NHP. Copeland Capital Management LLC bought a new position in National Healthcare Properties in the third quarter worth about $90,000. Sumitomo Mitsui DS Asset Management Company Ltd purchased a new stake in shares of National Healthcare Properties during the third quarter valued at about $175,000. Envestnet Asset Management Inc. bought a new stake in shares of National Healthcare Properties in the 2nd quarter valued at about $366,000. The Manufacturers Life Insurance Company bought a new stake in shares of National Healthcare Properties in the 2nd quarter valued at about $518,000. Finally, Readystate Asset Management LP bought a new stake in shares of National Healthcare Properties in the 2nd quarter valued at about $747,000.

About National Healthcare Properties

National Health Properties, Inc was a real estate investment trust that owned and leased healthcare-related properties in the United States. Its portfolio included healthcare facilities such as skilled nursing centers, assisted living communities, medical office buildings and other properties used by healthcare providers.

The company generally generated rental income through long-term leases with healthcare operators. Its business model focused on acquiring and managing income-producing healthcare real estate rather than directly providing medical or senior-care services.

National Health Properties was acquired by Ventas, Inc in 2015 and no longer operates as an independent publicly traded company.